| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.005 |